| mRNA |
OSI-930 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
4e-05 |
| mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
5e-05 |
| mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
5e-05 |
| mRNA |
BRD-K66453893 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-05 |
| mRNA |
SNX-2112 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
6e-05 |
| mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
6e-05 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
6e-05 |
| mRNA |
THZ-2-102-1 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
6e-05 |
| mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
6e-05 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
7e-05 |